Intramedullary metastasis of pulmonary carcinoma: Case report
18th International Conference on Neurology and Neurological Disorders
August 23-24, 2018 | Paris, France
Rachid Brahim Ghoul, Haddadi Y, M Nebbal, R Agoune and R Trad Khodja
Algiers Hospital Hca, Algeria
Posters & Accepted Abstracts : J Neurol Neurorehabil Res
Background: Intramedullary spinal cord metastasis (IMM)
of pulmonary carcinoma are extremely rare. Review of the
literature reveals only 300 cases documented.
Case description: A 54-year-old man K.S, a medical radiology technician, with history of chronic tobacco use presented with progressive tetraparsis with predominant weakness of the left limbs for 03 Months
Radiologic explorations: Resonance Imaging (MRI) of the cervical spine showed intradural intramedullary tumor at the spinal level of C4-C5.
The Treatment: In order to ovoid tetraplegia the patient underwent surgery with a total macroscopic tumor removal. Histopathology: Diagnosis of metastatic carcinoma, Thoracic CT showed a 1,27 X 1,42cm right hilar nodule. The patient was advised Chemotherapy and Radiation by oncologists.
Discussion: Intramedullary spinal cord metastasis pulmonary carcinoma is extremely rare, Theyrepresent 1% of all spinal cord tumors and 1-3% of intramedullary tumors. pulmonary cancers are the most frequent type of tumors with spinal cord metastasis (48% of cases.
Conclusion: Metastasis to the spinal cord is rare and may be the first manifestation of a primary cancer. Rapid progression of neurological symptoms should warrant imaging and may indicate metastasis to the spinal cord, especially in patients with previously diagnosed cancer. -Though the prognosis for metastatic pulmonary carcinoma patients is poor, early detection and appropriate treatment of such cancer patients may ameliorate symptoms and prolong good quality life.